C
Cerapedics
CeraPedics, a medical device company, focuses on developing and commercializing novel osteobiologic products
About Cerapedics
Cerapedics is a medical device company specializing in the development and commercialization of peptide-enhanced bone graft solutions. Operating in the orthopedic and spine surgery markets, Cerapedics serves healthcare providers, including surgeons and hospitals, by offering advanced bone graft products that enhance the natural bone healing process. The company's flagship product, i-FACTOR Peptide Enhanced Bone Graft, utilizes a unique small peptide attachment factor P-15 bound to anorganic bone mineral (ABM) to mimic the behavior of autograft bone, resulting in safe and predictable bone formation. Cerapedics generates revenue through the sale of its bone graft products, which are backed by extensive clinical research demonstrating their safety and efficacy. The company aims to improve patient outcomes and provide clinicians with reliable, evidence-based solutions for bone grafting procedures.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2000
- Headquarters
- Westminster, United States
- Employees
- 191
- Open positions
- 12
- Dealroom signal
- 34.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, User Behavior, Spinout, Spinal Disease, Biotech and Pharma, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Mar 2022 | $25M | $100M | Undisclosed | — |
| DEBTDebt | Jan 2019 | $45M | — | Armentum Partners | — |
Growth signals
Latest recorded traffic for Cerapedics is 3.8K monthly website visits, up 65.2% over the last three months. Cerapedics's team declined 1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
OrbiMed
NGN Capital
Series B and later4 investors entered at this stage
MedImmune Ventures- CVCVF
GE Capital
Armentum Partners
Other known investors1 additional known investor
University of Sherbrooke
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cerapedics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cerapedics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.